Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial

Journal of Clinical Oncology

Volumn 25, Issue 23, 2007, Pages 3475-3481

  Bruera, Eduardo ^a   El Osta, Badi ^a   Valero, Vicente ^a   Driver, Larry C ^a   Pei, Be Lian ^a   Shen, Loren ^a   Poulter, Valerie A ^a   Palmer, J Lynn ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; PLACEBO;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BEHAVIOR CHANGE; CANCER FATIGUE; CANCER LOCALIZATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SCORING SYSTEM; SIDE EFFECT; TACHYCARDIA; TREATMENT OUTCOME; VERTIGO;

AGED; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; INDANS; MALE; MIDDLE AGED; NEOPLASMS; NOOTROPIC AGENTS; PIPERIDINES; PLACEBOS; TELEMEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548166796     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.9231     Document Type: Article

References (31)

1. Vogelzang N, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tri-part assessment survey. Semin Hematol 34:4-12, 1997 (suppl 2)
2. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Cancer-related fatigue, version 2, 2007. http://www .nccn.org/professionals/physician_gls/PDF/fatigue.pdf
3. Bruera E, Neumann C, Brenneis C, et al: Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care 16:16-21, 2000
4. El Osta B, Bruera E: Models for palliative care delivery, in: Bruera E, Higginson I, Ripamonti C, et al (eds): Textbook of Palliative Medicine. London, United Kingdom, Hodder Arnold Publication, 2006, pp 266-276
5. Strasser F, Palmer JL, Schover LR, et al: The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: A pilot study. Cancer 107:2949-2957, 2006
6. Walsh D, Nelson KA: Autonomic nervous system dysfunction in advanced cancer. Support Care Cancer 10:523-528, 2002
7. Sweeney C, Neuenschwander H, Bruera E: Fatigue & asthenia, in Doyle D, Hanks G, Cherny NI, Calman K (eds): New York, NY, Oxford Textbook of Palliative Medicine, 2004, pp 560-568
8. Miaskowski C. Portenoy R.: Assessment and management of cancer related fatigue, in Berger A, Portenoy R, Weissman D (eds): Principles and Practice of Palliative Care and Supportive Oncology (ed 2). Philadelphia, PA, Lippincott Williams & Wilkins, 2002, pp 141-153
9. Bruera E, Strasser F, Shen L, et al: The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: A pilot study. J Pain Symptom Manage 26:1049-1054, 2003
10. Morrow GR, Hickok JT, Roscoe JA, et al: Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21: 4635-4641, 2003
11. Roscoe JA, Morrow GR, Hickok JT, et al: Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243-249, 2005
12. Bruera E, Valero V, Driver L, et al: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073-2078, 2006
13. Shaw EG, Rosdhal R, D'Agostino RB Jr, et al: Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol 24:1415-1420, 2006
14. Slatkin NE, Rhiner M, Bolton TM: Donepezil in the treatment of opioid-induced sedation: Report of six cases. J Pain Symptom Manage 21:425-438, 2001
15. Cella DF, Tulsky DS, Gray G: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
16. Yellen SB, Cella DF, Webster K, et al: Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage 13:63-74, 1997
17. Wu HS, McSweeny M: Measurement of fatigue in people with cancer. Oncol Nurs Forum 28:1371-1386, 2001
18. Reddy SG, Pace E, Zhang T, et al: What is a clinically significant improvement in the intensity of fatigue among cancer patients? J Clin Oncol 24: 483s, 2006 (suppl; abstr 8560)
19. Bruera E, Driver L, Barnes EA, et al: Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report. J Clin Oncol 21:4439-4443, 2003
20. Lee BN, Dantzer R, Langley K, et al: A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11:279-292, 2004
21. Del Fabbro E, Dalal S, Bruera E: Symptom control in palliative care: Part II. Cachexia/anorexia and fatigue. J Palliat Med 9:391-408, 2006
22. Bruera E, Neumann CM, Pituskin E, et al: Thalidomide in patients with cachexia due to terminal cancer: Preliminary report. Ann Oncol 10:857-859, 1999
23. Lundstrom SH, Furst CJ: The use of corticosteroids in Swedish palliative care. Acta Oncol 45: 430-437, 2006
24. Yennurajalingam S, Bruera E: Palliative management of fatigue at the close of life: "It feels like my body is just worn out." JAMA 297:295-304, 2007
25. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R: Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69:751-754, 1985
26. Porock D, Kristjanson LJ, Tinnelly K, et al: An exercise intervention for advanced cancer patients experiencing fatigue: A pilot study. J Palliat Care 16:30-36, 2000
27. Inoue A, Yamada Y, Matsumura Y, et al: Randomized study of dexamethasone treatment for delayed emesis, anorexia and fatigue induced by irinotecan. Support Care Cancer 11:528-532, 2003
28. Hardy JR, Rees E, Ling J, et al: A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 15:3-8, 2001
29. Morrow GR, Ryan JL, Kohli S, et al: Modafinil (Provigil) for persistent post-treatment fatigue: An open label study of 82 women with breast cancer. MASCC International Symposia, Toronto, Canada, June 22-24, 2006 (abstr 11-070)
30. Naschitz J, Dreyfuss D, Yeshurun D, Rosner I: Midodrine treatment for chronic fatigue syndrome. Postgrad Med J 80:230-232, 2004
31. Dimeo F, Stieglitz R, Novelli-Fischer U, et al: Effects of physical activity on the fatigue and psychological status of cancer patients during chemotherapy. Cancer 85:2273-2277, 1999